Omega Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.63 | -$0.14 | -$0.33 |
| Q2 2024 | 3 | -$0.69 | -$0.15 | -$0.37 |
| Q3 2024 | 3 | -$0.50 | -$0.11 | -$0.27 |
| Q4 2024 | 5 | -$0.30 | -$0.19 | -$0.25 |
| Q1 2025 | 4 | -$0.31 | -$0.17 | -$0.26 |
| Q2 2025 | 2 | -$0.51 | -$0.12 | -$0.27 |
| Q3 2025 | 2 | -$0.49 | -$0.11 | -$0.26 |
| Q4 2025 | 2 | -$0.50 | -$0.11 | -$0.26 |
Omega Therapeutics, Inc. Earnings Date And Information
Omega Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.3 earnings per share for the quarter, missing analysts' consensus estimates of $-0.29 by $0.01. The company had revenue of 2.61 M for the quarter and had revenue of 3.09 M for the year. Omega Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.8 diluted earnings per share) and currently has a price-to-earnings ratio of -0.59. Omega Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Omega Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.29 | -$0.30 | -0.01 | $700,000 | $2.61 M |
| 08/06/2024 | Q2 2024 | -$0.36 | -$0.30 | 0.06 | $956,143 | $2.13 M |
| 05/06/2024 | Q1 2024 | -$0.38 | -$0.36 | 0.02 | $2.36 M | |
| 03/28/2024 | Q4 2023 | -$0.37 | $989,000 | |||
| 11/09/2023 | Q3 2023 | -$0.56 | -$0.40 | 0.16 | $442,857 | $831,000 |
| 08/03/2023 | Q2 2023 | -$0.51 | -$0.54 | -0.03 | $378,571 | $759,000 |
| 05/04/2023 | Q1 2023 | -$0.64 | -$0.48 | 0.16 | $516,000 | |
| 03/01/2023 | Q4 2022 | -$0.62 | -$0.64 | -0.02 | $735,000 | |
| 11/08/2022 | Q3 2022 | -$0.63 | -$0.54 | 0.09 | $101,200 | $595,000 |
| 08/04/2022 | Q2 2022 | -$0.54 | -$0.54 | 0 | $51,500 | $476,000 |
| 05/04/2022 | Q1 2022 | -$0.57 | -$0.43 | 0.14 | $268,000 | |
| 03/10/2022 | Q4 2021 | -$0.57 | -$0.44 | 0.13 | $144,000 | |
| 11/10/2021 | Q3 2021 | -$0.49 | -$0.57 | -0.08 | $0 | |
| 09/10/2021 | Q2 2021 | -$1.21 | -$0.33 | 0.88 | $0 | |
| 03/30/2021 | Q1 2021 | -$0.43 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.30 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.26 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.20 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.17 | $0 |
Omega Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Omega Therapeutics, Inc.'s earnings date?
Omega Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Omega Therapeutics, Inc.'s earnings conference call?
The conference call for Omega Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Omega Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Omega Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Omega Therapeutics, Inc. generate each year?
Omega Therapeutics, Inc. (:OMGA) has a recorded annual revenue of $3.09 M.
-
How much profit does Omega Therapeutics, Inc. generate each year?
Omega Therapeutics, Inc. (:OMGA) has a recorded net income of $3.09 M. Omega Therapeutics, Inc. has generated $-1.8 earnings per share over the last four quarters.
-
What is Omega Therapeutics, Inc.'s price-to-earnings ratio?
Omega Therapeutics, Inc. (:OMGA) has a price-to-earnings ratio of -0.59 and price/earnings-to-growth ratio is -0.08.
